Literature DB >> 11914584

Molecular epidemiology of hepatitis B viral serotypes and genotypes in taiwan.

C J Liu1, J H Kao, P J Chen, M Y Lai, D S Chen.   

Abstract

Subtypes of hepatitis B virus (HBV) have specific geographic distributions and can serve as epidemiological markers. The relationship of HBV serotypes and genotypes in Taiwan and their correlation with the domiciles of origin in 122 patients with chronic HBV infection were investigated. The serotype of HBV was determined by comparing the surface gene encoding amino acids 22-148 of the major surface protein with published sequences. Genotyping of HBV was performed by polymerase chain reaction-restriction fragment length polymorphism. Serotype adw accounted for 70% (85/122) of all HBVs, with the remaining belonging to serotype adr. All adr HBVs were genotype C, regardless of the patient's domicile. Of the 85 adw HBVs, 69 (81%) were genotype B, 10 (12%) were genotype C, 5 (6%) were genotype F and only 1 (1%) was genotype A. In the 31 patients originating from mainland China, the prevalence of adr/genotype C was higher than in the 91 Taiwanese patients (15/31 vs. 22/91; p < 0.05). The distribution of the HBV serotypes and genotypes was not significantly different between 17 patients born in Taiwan (6 adw/genotype B, 2 adw/genotype C, 1 adw/genotype F and 8 adr/genotype C) and 14 patients born in mainland China (5 adw/genotype B, 2 adw/genotype C and 7 adr/genotype C). Our results indicate that in Taiwan, most HBVs of serotype adw are genotype B, and all HBVs of serotype adr are genotype C. Patients with origins in mainland China have a higher proportion of serotype adr/genotype C infection. Copyright 2002 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11914584     DOI: 10.1007/BF02256028

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  10 in total

Review 1.  Antiviral therapies: focus on hepatitis B reverse transcriptase.

Authors:  Eleftherios Michailidis; Karen A Kirby; Atsuko Hachiya; Wangdon Yoo; Sun Pyo Hong; Soo-Ok Kim; William R Folk; Stefan G Sarafianos
Journal:  Int J Biochem Cell Biol       Date:  2012-04-16       Impact factor: 5.085

Review 2.  Hepatitis B virus genotypes and variants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

3.  Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.

Authors:  Wen-Pin Su; Chi-Chung Wen; Chao-A Hsiung; Ih-Jen Su; Ann-Lii Cheng; Ming-Chih Chang; Chao-Jung Tsao; Woei-Yao Kao; Wu-Ching Uen; Chiun Hsu; Chih-Hung Hsu; Yen-Shen Lu; Hwei-Fan Tien; Tsu-Yi Chao; Li-Tzong Chen; Jacqueline Whang-Peng; Pei-Jer Chen
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

4.  Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B.

Authors:  Long H Nguyen; Nghiem B Ha; Philip Vutien; Nghi B Ha; Ruel T Garcia; Huy N Trinh; Brian S Levitt; Huy A Nguyen; Khanh K Nguyen; Emmet B Keeffe; Mindie H Nguyen
Journal:  Hepatol Int       Date:  2009-07-10       Impact factor: 6.047

5.  Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D.

Authors:  Orhan Yıldız; Bilgehan Aygen; Nese Demirtürk; Tuna Demirdal; Dilara Inan; Taner Yıldırmak; Arzu Kantürk; Ediz Tütüncü
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

6.  Molecular analysis of hepatitis B virus isolates in Mexico: predominant circulation of hepatitis B virus genotype H.

Authors:  Cosme Alvarado-Esquivel; Erwin Sablon; Carlos-Jesús Conde-González; Luis Juárez-Figueroa; Lilia Ruiz-Maya; Sergio Aguilar-Benavides
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

7.  Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.

Authors:  Yihu Zheng; Shengchu Zhang; Hooi Min Tan Grahn; Chao Ye; Zheng Gong; Qiyu Zhang
Journal:  Hepat Mon       Date:  2013-04-01       Impact factor: 0.660

8.  Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data.

Authors:  Stoyan Velkov; Ulrike Protzer; Thomas Michler
Journal:  Viruses       Date:  2020-11-23       Impact factor: 5.048

9.  Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil.

Authors:  Priscila A Tonetto; Neiva S L Gonçales; Viviane C Fais; Aline G Vigani; Eduardo S L Gonçales; Adriana Feltrin; Fernando L Gonçales
Journal:  BMC Infect Dis       Date:  2009-09-08       Impact factor: 3.090

10.  Common genotypes of Hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan.

Authors:  Muhammad Masroor Alam; Sohail Zahoor Zaidi; Shehzad Shaukat; Salmaan Sharif; Mehar Angez; Asif Naeem; Shamim Saleha; Javed Aslam Butt; Salman Akbar Malik
Journal:  Virol J       Date:  2007-06-28       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.